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Abstract
Introduction Introducing an intensive care unit (ICU)-based
medical emergency team (MET) into our hospital was
associated with decreased postoperative in-hospital mortality
after major surgery. The purpose of the present study was to
assess the effect of the MET and other variables on long-term
mortality in this patient population.
Methods We conducted a prospective, controlled, before-and-
after trial in a University-affiliated hospital. Participants included
consecutive patients admitted for major surgery (surgery
requiring hospital stay > 48 hours) during a four month control
phase and a four month MET phase. The intervention involved
the introduction of a hospital-wide ICU-based MET service to
evaluate and treat ward patients with acutely deranged vital
signs. Information on long-term mortality was obtained from the
Australian death registry. The main outcome measure was
patient mortality at 1500 days. Data on patient demographics,
surgery undertaken and whether the surgery was scheduled or
unscheduled was obtained from the hospital electronic
database. Multivariable analysis was conducted to determine
independent predictors of 1500-day mortality.
Results There were 1,369 major operations in 1,116 patients
during the control period and 1,313 operations in 1,067
patients during the MET (intervention) period. Overall survival at
1500 days was 65.8% in the control period and 71.6% during
the MET period (P = 0.001). Patients in the control phase were
statistically less likely to be admitted under orthopaedic surgery,
urology and faciomaxillary surgery units, but more likely to be
admitted under cardiac surgery or neurosurgery units. Patients
in the MET period were less likely to undergo unscheduled
surgery. Multivariable analysis revealed that age, unscheduled
surgery and admission under thoracic surgery, neurosurgery,
oncology and general medicine were independent predictors of
increased 1500-day mortality. Admission during the MET period
was also an independent predictor of decreased 1500-day
mortality (odds ratio 0.74; P = 0.005).
Conclusion Introduction of a MET service in a teaching hospital
was associated with increased long-term survival even after
adjusting for other factors that contribute to long-term surgical
mortality.
Introduction
Serious adverse events (SAEs) are common among patients
admitted to hospital [1]. A review of 30,121 medical records
in New York State showed that SAEs affected nearly 4% of all
admissions, of which 13.6% led to death [2]. Similar findings
have been reported in Australia [3], Canada [4] and the UK
[5], demonstrating that this is a worldwide problem. In a study
of patients undergoing major surgery in our hospital, 16.9%
suffered SAEs and 7.1% died [6].
Cardiac arrests and SAEs in hospital patients are typically not
sudden or unexpected. Several studies have demonstrated
that these events are heralded by derangements of commonly
measured vital signs during the preceding 24 hours [7-9].
Medical emergency teams (METs), an example of a Rapid
Response System (RRS), have been introduced into hospitals
to identify, review and treat at-risk patients during the early
phase of deterioration. The hypothesis underlying this
ICU = intensive care unit; MET = medical emergency team; SAE = serious adverse event; RRR = relative risk reduction.Critical Care    Vol 11 No 1    Jones et al.
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approach is that early intervention in the course of deteriora-
tion improves outcome.
In a previous study [10] we demonstrated that introducing a
MET service into our hospital was associated with decreased
postoperative SAEs, postoperative mortality and mean dura-
tion of hospital stay. However, this study only reported on
postoperative mortality to the point of hospital discharge. Fur-
thermore, it did not account for possible confounders that
might have contributed to the observed outcome differences.
The aim of the present study was to assess the effect of intro-
ducing a MET service on long-term survival (to 1500 days, or
4.1 years) in a cohort of patients undergoing major surgery at
our hospital. In addition, we assessed patient, procedure and




We obtained Hospital Human Research Ethics Committee
approval for implementation of the MET and for collection of
data related to the study. The need for informed consent was
waived by the Hospital Human Research Ethics Committee.
A separate ethics approval was obtained from the Australian
Registry of Deaths for permission to follow up and cross-refer-
ence outcomes in our cohort of patients with the Australian
Registry of Deaths, which records the deaths of all Australian
citizens.
The Hospital
Austin Health is a teaching hospital of the University of Mel-
bourne. It has two campuses located in the north-east of Mel-
bourne, a city with a population of nearly 4 million. One
campus (400 beds) receives all acute admissions and the
other caters for aged care and rehabilitation admissions. The
acute care campus admits approximately 60,000 patients per
year and is the campus where this study was conducted. The
acute care campus has 21 ICU beds that admit approximately
1,800 patients per year. The ICU operates according to the
'closed' ICU model, where only ICU physicians can prescribe
treatment.
Preintervention rapid response team structure
Before the introduction of the MET, the hospital rapid
response team was based on the traditional cardiac arrest
team concept. Cardiac arrest team members carried pagers
that were activated during the 'code blue' call. All wards are
equipped with resuscitation trolleys containing resuscitation
drugs and semi-automated defibrillators. The cardiac arrest
team included a cardiology fellow, an intensive care fellow, a
coronary care nurse and the receiving medical unit fellow of
the day. This cardiac arrest response system remained unal-
tered throughout the study.
The medical emergency team
Any member of hospital clinical staff (including nurses, physi-
otherapists, social workers, speech therapists, residents and
members of senior medical staff) could activate the MET. The
members of the MET included the duty intensive care fellow, a
designated intensive care nurse and the receiving medical fel-
low. An ICU specialist was available to attend, if requested,
from 08:00 until 20:00 hours. After hours, an intensive care
specialist was available within 15 to 30 minutes for attendance
if required. The criteria for MET activation were available in the
form of a large red poster that was displayed prominently in
each ward. Specifically, if any of the following conditions were
present, staff were instructed to call 7777 and ask for the
MET: staff member is worried about the patient; acute change
in heart rate to < 40 or > 130 beats/minute; acute change in
systolic blood pressure to < 90 mmHg; acute change in respi-
ratory rate to < 8 or > 30 breaths/minute; acute change in
pulse oximetry saturation to < 90% despite oxygen administra-
tion; acute change in conscious state; and acute change in
urine output to < 50 ml in four hours.
The MET was activated by a pager call and by a public
announcement internal communication call saying 'medical
emergency team to ward X'. The MET was equipped with an
emergency pack containing drugs and equipment needed for
resuscitation and endotracheal intubation. After a MET call, if
the patient was not admitted to ICU, then the MET visit was
considered a formal consult, the parent unit was contacted,
and concerns, advice and suggestions were verbally commu-
nicated and recorded in the patient's chart.
Study design
The study design was that of a prospective controlled before-
and-after intervention trial. All patients admitted to hospital
who had major surgery were considered participants. Major
surgery was defined as any operation associated with a hospi-
tal stay longer than 48 hours. In the present study we
assessed the long-term mortality of the cohorts of patients
reported in the original publication [10]. The follow-up time of
1500 days (4.1 years) represented the longest follow-up
period for the MET (intervention) study cohort at the time of
data acquisition from the Australian Registry of Deaths. To
maintain consistency between the MET and control periods,
outcome data were censored at this time.
Study periods
The 'before' period was a four month period (control period)
encompassing 1 May 1999 to 31 August 1999 (winter), dur-
ing which outcome measures were studied under normal oper-
ating conditions of the hospital. This period was followed by a
preparation and education period (1 September 1999 to 31
August 2000) to allow the introduction of the MET [10-12].
During this period the concept of the MET was presented in
the form of lectures and tutorials to hospital administration,
nursing staff and paramedical personnel (physiotherapists andAvailable online http://ccforum.com/content/11/1/R12
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speech therapists). Extensive and repeated presentations and
discussions were held with all members of medical staff.
Objections were raised and addressed at these meetings. The
MET was then implemented and a run-in period of two months
was allowed. This was done to ensure that there were no logis-
tic or political problems with its implementation and that all
members of hospital staff would become familiar with its use.
The 'after' period was the following four month period (inter-
vention period) encompassing 1 November 2000 to 28 Feb-
ruary 2001 (spring and summer) during which the outcome
measures were studied under the new (availability of MET)
operating conditions of the hospital.
Patients
The analysis included all patients who had undergone in-
patient surgery during the study period and who remained in
hospital for 48 hours or more after surgery. The 48-hour limit
was used to exclude patients having day surgery or minor pro-
cedures who were not expected to be at risk for SAEs.
Data collection
We collected baseline demographical data (patient age and
sex, procedure undergone) as well as hospital systems data
(surgical specialty of admission, scheduled or unscheduled
status of surgery). Information on long-term outcome was
obtained from the Australian Registry of Deaths.
The number of procedures in each of 83 operative categories
for both the control period and the intervention phase was col-
lated to allow comparison. For the purposes of multivariable
analysis, these 83 operative categories were then grouped
into 37 operation clusters (labeled 1 to 37; Table 1). All colla-
tion and grouping was performed by a single investigator (DJ)
who was blinded to patient outcome. Similarly, the investigator
performing outcome analysis (ME) was blinded to the classifi-
cation of the operation clusters (which were labeled 1 to 37)
and the admitting unit.
Outcome measures
The primary outcome measure for the study was the time to
death (in days) from the date of admission. When performing
multivariate logistic regression analysis, vital status at 1500
days was used as the dependent variable.
Statistical analysis
Computerized statistical packages were used for data analysis
and descriptive statistics (Statview [Abacus Inc., Berkeley,
CA, USA] and SPSS 12.0 [SPSS Inc, Chicago, IL, USA]).
Descriptive data are presented as mean ± standard deviation.
Comparisons of nominal data for differences in proportions
between the two study periods were performed using χ2 or
Fisher's exact test.
Cumulative mortality was determined using the Kaplan-Meier
product limit method of survival estimation, and comparison of
survival of patients in the MET and control periods was per-
formed using the log-rank test, censoring survival at 1500
days.
We also performed multivariate logistic regression analysis
using age (in ten year intervals), sex, unscheduled surgery, unit
of admission, operation cluster (1 to 37) and MET period as
independent variables, and vital status at 1500 days as the
dependent variable. A forward stepwise elimination process
was then used to remove covariates whose multivariate P
value was > 0.10. The final model contained all predictors of
mortality with a multivariate P < 0.10. In all multivariate logistic
regression analyses, we sought to assess the following: the
discrimination of the model with the percentages of appropri-
ately classed patients in the final model; the calibration of the
model with Hosmer-Lemeshow test; and the role of multicol-
linearity with the variance inflation factor. Every variance infla-
tion factor was less than 5, indicating absence of severe
multicollinearity.
For all statistical analysis, P < 0.05 was considered statisti-
cally significant.
Results
Baseline characteristics of the patient cohorts
During the control period, 1,369 procedures were conducted
in 1,116 patients, and during the MET period 1,313 proce-
dures were conducted in 1,067 patients (Table 2). The aver-
age age and proportion of female patients in the two periods
was similar. Patients in the control period were statistically
more likely to be admitted under units for cardiac or neurosur-
gery, and less likely to be admitted under units for orthopaedic
surgery, urology, and ear nose and throat/faciomaxillary sur-
gery (Table 2).
Differences in surgical procedures performed in the 
control and MET periods
Patients admitted during the MET period were less likely to
undergo unscheduled surgery than those admitted during the
control period (Table 3). In addition, patients admitted in the
MET period were less likely to undergo valvular cardiac and
aortic arch surgery, hepatobiliary, pancreatic, or splenic resec-
tion, vascular bypass and fistula surgery, and certain forms of
neurosurgery (Table 3). In contrast, patients admitted during
the MET period were more likely to undergo certain forms of
orthopaedic and urological surgery (Table 3).
Differences in long-term mortality of patients admitted 
during the control and MET periods
Patients admitted during the MET period had improved 1500-
day (4.1-year) survival compared with those admitted during
the control period (Figure 1). At 1500 days there were 381
deaths in the control period and 303 deaths in the MET period.Critical Care    Vol 11 No 1    Jones et al.
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Table 1
Characteristics of operation clusters 1 to 37
Operation cluster Operations contained within the cluster
1. Open heart/thoracic aortic surgery Aortic valve surgery with/without CABG surgery
Aortic and mitral valve surgery
Mitral valve surgery with/without CABG surgery
Thoracic aortic repair/replacement
CABG surgery and ventricular surgery
CABG surgery and CEA
2. CABG surgery CABG surgery
3. Resective thoracic surgery Reoperation after cardiac surgery
Sternal wound repair/closure
Pericardial surgery
Lobectomy or wedge resection




4. Pleural surgery Pleurodesis
Pleural decortication
Drainage of empyema
5. Bronchoscopy Brochoscopy (including laser and stent)
6. Upper gastrointestinal surgery Oesophageal surgery
Gastric resection/binding
7. Intestinal endoscopy/insertion of Oesophagoscopy (including laser/stent)
feeding tube Endoscopy
Insertion of feeding tube
8. Appendicectomy Appendicectomy
9. Hepatobilary or pancreatic surgery Gall gladder/biliary surgery
ERCP/bile duct manipulation
Pancreatic/spleen resection
Liver resection/portocaval shuntAvailable online http://ccforum.com/content/11/1/R12
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10 Breast surgery Breast surgery
11. Bowel surgery/hernia repair Bowel resection/stoma formation or reversal
Hernia repair
12. Head and neck, facial surgery Thyroid/parathyroid surgery




13. Wound debridement/mass biopsy Wound debridement/mass biopsy
14. Haemorroid/perianal surgery Haemorroid/perianal surgery
15. Laparotomy other Tenkoff catheter insertion
Laparotomy other
16. Hip fracture Hip replacement/dynamic hip screw
17. Joint aspiration/lavage Joint aspiration/lavage/scope
18. Spinal fusion/laminectomy Spinal fusion/laminectomy
19. Amputation Amputation
20. Limb fracture Repair fracture upper limb
Repair fracture lower limb
21. Orthopedic other Joint reconstruction/relocation
Removal of prosthesis
Tendon repair
22. Vascular bypass or Lower limb vascular bypass
endarterectomy/fistula surgery Upper limb vascular procedure
Carotid endarterectomy
Formation/exploration of fistula
23. Abdominal aortic aneurysm Abdominal aortic aneurysm repair
24. Other vascular surgery Renal transplant
Varicose veins surgery
Table 1 (Continued)
Characteristics of operation clusters 1 to 37Critical Care    Vol 11 No 1    Jones et al.
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25. Cerebral aneurysm clipping Aneurysm clipping
26. Draining ICH/abscess Removal of ICH or AVM
Drainage of intra-cranial abscess
27. Cerebral lobectomy/tumour resection Removal of brain tumour
Temporal lobectomy
28. Neurosurgery other Insertion of spinal catheter
Insertion/removal of VP shunt
Neurosurgical other
29. Plastic surgical procedure Hand surgery
Removal of skin cancer and split skin graft
Wound debridement and split skin graft
Flap formation/reconstruction
30. Liver transplant Liver transplant
31. Anaesthetic procedure Elective direct current reversion
Insertion of invasive lines
MRI
Other
32. Cystoscopy Cystoscopy with/without transurethral resection of
bladder tumour
33. Transurethral resection of prostate Transurethral resection of prostate
34. Open prostatectomy Open prostatectomy
35. Nephrectomy Nephrectomy
36. Urology other Cystectomy and ileal conduit formation
Urolithiasis surgery
37. Gynaecological procedure TAH and/or oophorectomy
Dilatation and curretage
Gynaecology other
AVM, arteriovenous malformation; CABG, coronary artery bypass graft; CEA, carotid end-arterectomy; ERCP, endoscopic retrograde 
cholangiopancreatography; ICH, intracerebral haemorrhage; MRI, magnetic resonance imaging; TAH, total abdominal hysterectomy; VP, 
ventriculoperitoneal.
Table 1 (Continued)
Characteristics of operation clusters 1 to 37Available online http://ccforum.com/content/11/1/R12
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Thus, the 1500-day rates of survival for patients admitted dur-
ing the MET and control periods were 71.6% and 65.8%,
respectively (log-rank test P = 0.001). The odds ratio of death
at 1500 days during the MET period was 0.77 (95% confi-
dence interval 0.64–0.92; P = 0.004) compared with the con-
trol period. This survival benefit was seen for each yearly
interval (Table 4).
Analysis of factors contributing to death
Multivariable analysis of data for patients in both the MET and
control periods revealed a number of independent predictors
of death (Table 5).
Increasing age, nonscheduled surgery and admission under
units for thoracic surgery, neurosurgery, oncology and general
medicine were all independent risk factors for death at 1500
days. Similarly, the operation clusters of bronchoscopy, cere-
bral resection and cystoscopy (with/without bladder resection
of tumour) were independently associated with increased risk
for death at 1500 days.
Female sex and admission under units for cardiac surgery, vas-
cular surgery and the liver transplant unit were independently
associated with decreased risk for death at 1500 days, as
were the operation clusters of breast surgery and spinal
fusion. After adjusting for other confounding factors, admis-
sion during the MET period was an independent predictor of
survival at 1500 days (multivariate odds ratio 0.74, 95% con-
fidence interval 0.60–0.92; P = 0.005).
Discussion
We conducted a follow-up study to assess the long-term sur-
vival of the original cohort of patients undergoing major sur-
gery at our hospital [10]. In addition, we assessed the effect of
the introduction of a MET service on the outcome of such
patients in comparison with a cohort treated before its intro-
duction. Finally, we assessed for possible confounders that
Table 2
Comparison of the demographics and allocation units for patients admitted during the control and MET periods
Control period MET period P value
Number of patients 1116 1067 -
Age average (standard deviation) 60.8 (19.7) 60.1 (19.5) 0.46
Percentage female 41.52 42.61 0.49
Number of procedures 1369 1313
Procedures per parent unit
Cardiac surgerya 188 141 0.04
Thoracic surgery 141 117 0.22
General surgery/colorectal 288 313 0.08
Orthopaedic surgerya 253 289 0.02
Vascular surgery 160 132 0.17
Haematology 5 1 0.22
Neurosurgerya 147 112 0.05
Plastic surgery 77 84 0.40
Spinal injury unit 3 5 0.50
Liver transplant unit 28 15 0.06
Nephrology 8 2 0.11
Cardiology 4 4 >0.99
Oncology 6 2 0.29
Urologya 23 48 0.001
Gynaecology 7 12 0.21
Paediatric surgery 11 8 0.55
General medicine 10 3 0.09
ENT/faciomaxillary surgerya 9 24 0.005
aIndicates statistically significant differences in the proportion of admissions. ENT, ear, nose and throat; MET, medical emergency team.Critical Care    Vol 11 No 1    Jones et al.
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might explain the observed differences (mortality, hospital
length of stay and SAEs) of our original publication dealing
with short-term outcomes [10]. We found that at 1500 days
there was a significant 5.8% absolute decrease in long-term
mortality among patients treated during the MET period, and
that admission during the MET period was an independent
predictor of 1500-day survival.
A previous study [6] of 1,125 patients undergoing major sur-
gery (defined as surgery requiring admission for > 48 hours)
in our hospital revealed that 16.9% suffered SAEs and 7.1%
died. In addition, age above 75 years and unscheduled sur-
gery were predictors of increased risk for in-hospital death. In
the present study we confirm that these variables also
adversely affect survival to 1500 days.
Subsequently, we demonstrated that the introduction of a
MET service was associated with a relative risk reduction
(RRR) for postoperative hospital mortality of 36.6%, as well as
reductions in ICU admissions (RRR 44.4%) and SAEs (RRR
59.5%) [10]. However, this study did not assess for possible
confounders that might have influenced the observed differ-
ences in outcome, and its findings were accordingly the sub-
ject of criticism. In the present study we have shown that a
difference in patient mortality was sustained to a period of
1500 days, and that on day 1500 the odds ratio of death for
patients admitted during the MET period was 0.77 compared
with the control period (RRR 23%).
Our study revealed that there were a number of differences in
the patient cohorts in the MET and control periods. We also
identified a number of factors that were independent predic-
tors of increased risk for long-term death, including increasing
patient age, male sex, unscheduled surgery and admission
under thoracic surgery, neurosurgery, oncology, or general
medicine. After adjustment for all assessable confounders, we
found that admission during the MET period was associated
with a statistically reduced chance of long-term death when
compared with admission during the control period. If this
effect could be reproduced elsewhere, then the public health
consequences would be important. Indeed, in response to
preliminary findings that the MET approach may benefit hospi-
tal patients, the Institute for Health Improvement has launched
a nationwide initiative to introduce such teams in many Ameri-
can hospitals [13]. Thus, knowing whether the putative in-hos-
pital benefits achieved with such teams translate into long-
term advantages might be crucial in justifying and sustaining
the impetus of such a campaign.
Table 3
Differences in the nature of operation clusters for patients admitted in the control and MET periods
Control period MET period P value (OR, 95% CI)
Nonscheduled surgery 674 563 <0.0001 (0.66, 0.57–0.77)
Cardiac/thoracic aortic surgery (not CABG surgery) 73 41 0.001 (0.52, 0.35–0.77)
Hepatobiliary, pancreatic, and splenic surgery 96 74 0.04 (0.72, 0.52–0.99)
Orthopaedic 'other' 26 57 0.001 (2.15, 1.34–3.44)
Vascular bypass/fistula surgery 95 58 0.0008 (0.57, 0.41–0.79)
Intracranial haemorrhage/abscess drainage 29 9 0.0007 (0.29, 0.14–0.62)
Neurosurgery 'other' 42 27 0.04 (0.61, 0.37–0.99)
Anaesthesia related 12 26 0.03 (2.1, 1.05–4.20)
Urology 'other' 4 23 0.0004 (5.60, 1.92–16.2)
The characteristics of the operation clusters are outlined in Table 1. CABG, coronary artery bypass grafting; CI, confidence interval; MET, medical 
emergency team; OR, odds ratio.
Figure 1
Kaplan-Meier survival curves for patients admitted during control and  MET periods to 1500 days Kaplan-Meier survival curves for patients admitted during control and 
MET periods to 1500 days. MET, medical emergency team.Available online http://ccforum.com/content/11/1/R12
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The reduction in mortality between the two study cohorts is
perhaps greater than would be expected from the absolute
number of MET reviews. We believe that education of hospital
staff and the cultural change accompanying the MET is likely
to be a substantial contributor to the observed differences in
patient outcome associated with the introduction of the MET
service.
Our study has several strengths, including a prospective
design; verifiable, independent and robust outcome; evidence
of a clear effect both before and after adjustment for con-
founding variables; and a suitable rate of intervention by MET.
However, it also has important limitations. First, it was neither
double blinded nor placebo controlled or randomized. How-
ever, it is not possible to achieve double blinding to interven-
Table 4
Analysis of survival difference between MET and control period for patients undergoing major surgery
Hospital dischargea 1 year 2 years 3 years 4.1 years
Deaths control period 73 195 271 337 382
Deaths MET period 45 133 189 239 303
OR for death 0.57 0.68 0.70 0.71 0.77
95% CI 0.39–0.84 0.55–0.85 0.58–0.84 0.60–0.84 0.64–0.91
P value 0.004 0.001 <0.001 <0.001 0.003
aAs per original publication [10]. CI, confidence interval; MET, medical emergency team; OR, odds ratio.
Table 5
Multivariate logistic regression analysis for death within 1500 days after surgery for patients admitted in both the control and MET 
periods
Odds ratio 95% CI P value VIF
Age (per 10 years) 1.73 1.61–1.86 <0.001 1.09
MET perioda 0.74 0.60–0.92 0.005 1.02
Female sex 0.72 0.58–0.89 0.002 1.05
Nonscheduled surgery 1.51 1.21–1.89 <0.001 1.18
Admitting unit
Cardiac surgery 0.33 0.22–0.48 <0.001 1.28
Thoracic surgery 2.76 1.89–4.03 <0.001 1.36
Orthopaedic surgery 0.50 0.37–0.69 <0.001 1.43
Vascular surgery 0.66 0.46–0.94 0.023 1.20
Neurosurgery 1.60 1.03–2.48 0.036 1.63
Liver transplant unit 0.30 0.09–1.03 0.056 1.05
Oncology 10.48 1.2–91.65 0.034 1.01
General medicine 3.00 1.13–7.95 0.027 1.02
Procedure
Bronchoscopy 3.13 1.24–7.88 0.015 1.16
Breast surgery 0.20 0.04–0.95 0.043 1.04
Spinal fusion 0.34 0.17–0.68 0.002 1.21
Cerebral resection 3.30 1.6–6.77 0.001 1.33
Cystoscopy ± bladder 
tumour resection
2.90 1.04–8.08 0.042 1.02
The characteristics of the operation clusters are outlined in Table 1. For this model, the Hosmer-Lemeshow goodness-of-fit statistic was 13.1 (P = 
0.11). The percentage of appropriately classified patients in the final model is 75.3%. aThe OR and 95% CI for introduction of the MET pertains to 
that derived from the multivariate model. CI, confidence interval; OR, odds ratio; VIF, variance inflation factor.Critical Care    Vol 11 No 1    Jones et al.
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tion by a MET in a single-centre study. Furthermore,
introducing a 'sham' intervention as a placebo was considered
ethically untenable.
The second limitation is that our analysis revealed differences
in characteristics of the patient cohorts admitted during the
control and MET periods. However, the beneficial effect of the
introduction of the MET service on the long-term outcome of
the patients persisted even after adjustment for multiple fac-
tors. Nonetheless, we cannot account for other factors that
were not assessed but might also have affected patient out-
comes. Such factors, rather than the introduction of the MET,
might explain our findings.
Our multivariate analysis also identified a number of conditions
and surgical procedures that were independent predictors of
long-term mortality. It is likely that these differences are due to
the prognosis of the underling condition (for example, admis-
sion under oncology, general medicine, or neurosurgery). We
are unable to comment as to whether the introduction of the
MET service was associated with improved outcomes from
these conditions. Further work is required to determine
whether these conditions or procedures are associated with
increased incidence of MET criteria and conditions for which
the MET could intervene. We are also unable to comment on
the effect of seasonal variation on the differences in observed
patient mortality between the two study periods. However, our
analysis did identify differences in baseline characteristics of
the surgical conditions performed, and yet the benefits of the
MET persisted even after adjustment for these differences.
The third limitation of our study is that it demonstrates findings
in a single institution only in a particular country. Its findings
might not apply to other hospitals or health care systems.
However, our institution has all the organizational, structural,
logistic and clinical performance features of a typical tertiary
referral hospital in a developed country. Nonetheless, it is
important to note that the Medical Early Response Intervention
and Therapy (MERIT) Study, a cluster multicentre randomized
controlled trial of the introduction of the MET in 23 hospitals in
Australia, failed, on direct comparison, to show a significant
benefit of METs on several important outcomes [14]. A
number of differences exist between the MERIT study and our
study that may explain these findings. First, the MERIT study
did not focus on mortality among patients undergoing major
surgery. Second, because of the large hospital-to-hospital var-
iability and the limited number of centres, the study was statis-
tically underpowered. Third, the 'dose' of MET calls in our
study (52/1067 = 48.7 METs/1,000 patients) was 5.6 times
that of the MERIT study (8.7 emergency calls/1,000 admis-
sions). This difference in MET use may be explained by the
longer education and preparation period for our study (12
months) compared with the MERIT study (4 months).
Finally, our study demonstrates reduction in long-term mortal-
ity for surgical patients only. The effect on medical patients
was not assessed. During the study period there were more
than 8,000 medical admissions, making analysis of differences
in baseline characteristics and admission diagnosis
exceedingly complex. In addition, it is our clinical observation
that medical patients have many more chronic comorbidities
and fewer acute physiological derangements amenable to
intervention and correction by the MET. Nonetheless, we have
previously demonstrated that introduction of the MET service
was associated with a reduction in the incidence of cardiac
arrests in medical patients [11].
Conclusion
Introduction of an ICU-based MET was associated with an
improvement in the long-term outcome of patients undergoing
major surgery in a tertiary hospital. Similar studies of long-term
outcome for surgical patients from other institutions or health
care systems considering the introduction of rapid response
systems are now needed to confirm or refute our observations.
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